Table 2.
Clinical characteristics of the study sample (children)
Group1 | Group2 | |
---|---|---|
TN → SC* | SC → TN* | |
(n = 30) | (n = 25) | |
Diagnosis | ||
Behçet syndrom | 0 | 1 (4%) |
JIA (enthesitis-related) | 9 (30%) | 7 (26%) |
JIA (undifferenciated) | 1 (3%) | 2 (8%) |
JIA (oligoarticular) | 5 (17%) | 10 (37%) |
JIA (polyarticular) | 0 | 4 (15%) |
JIA (systemic) | 1 (3%) | 0 |
Chronic osteomyelitis | 1 (3%) | 1 (4%) |
Auto-inflammatory disease | 0 (0%) | 1 (4%) |
Juvenile dermatomyositis (JDM) | 1 (3%) | 0 (0%) |
Uveitis | 2 (7%) | 1 (4%) |
Chronic infantile neurological cutaneous articular (CINCA) syndrom | 1 (3%) | 0 |
Lupus | 1 (3%) | 0 |
Crohn’s disease | 1 (3%) | 0 |
Undetermined | 4 (13%) | 0 |
Severity a | ||
Mild/moderate | 27 (90%) | 23 (92%) |
Severe | 3 (10%) | 2 (8%) |
Allocation order of TN telenursing; SC standard care, for 12 months each. JIA juvenile idiopathic arthritis
aSeverity of the disease was assessed prior randomization, by the treating physician using the
JADAS